// App-Quantinova.ai

77 : A phase II study to evaluate the effects of docetaxel plus lycopene in advanced castrate-resistant prostate cancer.

Researchers

Presenter

  • Eric Zhuang

Principal Investigators

  • Edward M. Uchio

  • Michael B. Lilly

  • John P. Fruehauf

Medical Centers

  • University of California Irvine Medical Center, Orange, CA

  • UCI Comprehensive Cancer Center, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT01882985

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved